“…Immunofluorescence experiments were performed, as previously described, 19,30 using primary antibodies directed against E-cadherin (Zymed Laboratories Inc., San Francisco, CA, USA), anti-aSMA (Sigma-Aldrich), anti-keratin 14 (Eurogentec, Angers, France), anti-keratin 8/18 (Spring Biosciences, Pleasanton, CA, USA), anti-CD31 (BD Bioscience, Le Pont de Claix, France), anti-vimentin (Fitzgerald Industries International, Acton, MA, USA) at recommended concentrations. After washing, slides were incubated with fluorescent Alexa-488-and Cy3-conjugated secondary antibodies (Jackson Immuno Research, West Grove, PA, USA).…”